NCT02939079View on ClinicalTrials.gov

Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

October 31, 2016

Conditions
Multiple Sclerosis
Interventions
DRUG

Fingolimod

Produced by Osveh ® Pharm Company in Iran

DIETARY_SUPPLEMENT

Fish Oil

produced by Zahravi ® Pharm Company in Iran

DRUG

Placebo (for Fish Oil)

placebo capsules to mimic Fish Oil 1 g capsules

All Listed Sponsors
collaborator

Shiraz University of Medical Sciences

OTHER

lead

Isfahan University of Medical Sciences

OTHER

NCT02939079 - Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter